Patient preferences for active surveillance vs standard surgery after neoadjuvant chemoradiotherapy in oesophageal cancer treatment: The <scp>NOSANO</scp> ‐study-Reference-Cited by-同舟云学术

Patient preferences for active surveillance vs standard surgery after neoadjuvant chemoradiotherapy in oesophageal cancer treatment: The NOSANO ‐study

Published:2022-10-27 Issue:6 Volume:152 Page:1183-1190
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Intl Journal of Cancer

Author:

Hermus Merel¹^ORCID,van der Wilk Berend J.²,Chang Rebecca T. H.¹,Collee Gerlise¹,Noordman Bo J.²,Coene Peter‐Paul L. O.³,Dekker Jan Willem T.⁴,Hartgrink Henk H.⁵,Heisterkamp Joos⁶,Nieuwenhuijzen Grard A. P.⁷,Rosman Camiel⁸,Timmermans Liesbeth⁹,Wijnhoven Bas P. L.²,van der Zijden Charlène J.²,Busschbach Jan J.¹,van Lanschot J. Jan B.²,Lagarde Sjoerd M.²,Kranenburg Leonieke W.¹

Affiliation:

1. Department of Psychiatry Section Medical Psychology and Psychotherapy, Erasmus University Medical Center Rotterdam The Netherlands

2. Department of Surgery Erasmus Cancer Institute, Erasmus University Medical Center Rotterdam The Netherlands

3. Department of Surgery Maasstad Hospital Rotterdam The Netherlands

4. Department of Surgery Reinier de Graaf Hospital Delft The Netherlands

5. Department of Surgery Leiden University Medical Center Leiden The Netherlands

6. Department of surgery Elisabeth Tweesteden Hospital Tilburg The Netherlands

7. Department of Surgery Catharina Hospital Eindhoven The Netherlands

8. Department of Surgery Radboud University Medical Center Nijmegen The Netherlands

9. Department of Primary and Community Care Radboud University Medical Center Nijmegen The Netherlands

Funder

Maag Lever Darm Stichting

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.34327

Reference24 articles.

1. Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial

2. Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer

3. Neoadjuvant chemoradiotherapy plus surgery versus active surveillance for oesophageal cancer: a stepped-wedge cluster randomised trial

4. Accuracy of Detecting Residual Disease After Neoadjuvant Chemoradiotherapy for Esophageal Cancer

5. BedenneL MarietteC.Comparison of systematic surgery versus surveillance and rescue surgery in operable oesophageal cancer with a complete clinical response to radiochemotherapy (Esostrate). Available at: ClinicalTrials.gov Identifier: NCT02551458;2015.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Decision-making experiences of patients and partners opting for active surveillance in esophageal cancer treatment;Patient Education and Counseling;2024-10

2. Patterns of Care and Outcomes of Patients with Small Gastrointestinal Stromal Tumors at a High-Volume Sarcoma Center;Annals of Surgical Oncology;2024-09-04

3. Treatment Response to Neoadjuvant Therapy in Squamous Esophageal Cancer—Correlation Between Metabolic Response and Histopathology;Journal of Gastrointestinal Cancer;2024-02-03

4. Surgeon's steering behaviour towards patients to participate in a cluster randomised trial on active surveillance for oesophageal cancer: A qualitative study;European Journal of Surgical Oncology;2023-10

5. Esophageal cancer patients’ need for information and support in making a treatment decision between standard surgery and active surveillance;Cancer Medicine;2023-07